OnabotulinumtoxinA: An Effective Tool in the Therapeutic Arsenal for Chronic Migraine With Medication Overuse

by Edoardo Caronna, Victor José Gallardo, Natalia Hernández-Beltrán, Marta Torres-Ferrus, Marta Torres-Ferrus, Patricia Pozo-Rosich, Patricia Pozo-Rosich
Published 2018-10-01

Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinA

by Marta Torres-Ferrus, Victor José Gallardo, Alicia Alpuente, Patricia Pozo-Rosich
Published 2020-07-01

Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months

by Edoardo Caronna, Victor José Gallardo, Alicia Alpuente, Marta Torres-Ferrus, Patricia Pozo-Rosich
Published 2021-10-01

Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation

by Lars Bendtsen, Simona Sacco, Messoud Ashina, Dimos Mitsikostas, Fayyaz Ahmed, Patricia Pozo-Rosich, Paolo Martelletti
Published 2018-09-01

The impact of onabotulinumtoxinA on severe headache days: PREEMPT 56-week pooled analysis

by Manjit Matharu, Rashmi Halker, Patricia Pozo-Rosich, Ronald DeGryse, Aubrey Manack Adams, Sheena K. Aurora
Published 2017-08-01

Proposal of a clinical care pathway for quality and safe management of headache patients: a consensus study report

by Patricia Pozo-Rosich, Julio Pascual, Sandra Rodríguez-Justo, Dolores Jiménez-Hernández, Almudena Layos-Romero, Cristina Bailón-Santamaría, Antonio Torres, Alba Martínez-García, Emilio Ignacio
Published 2020-10-01

Low-value care practice in headache: a Spanish mixed methods research study

by Patricia Pozo-Rosich, Almudena Layos-Romero, Jimmy Martin-Delgado, Julio Pascual, Cristina Bailón, Ana Tentor, Alejandro Santiago, Emilio Ignacio, Antonio Torrés, José Joaquín Mira
Published 2020-06-01

Cortical metabolic and structural differences in patients with chronic migraine. An exploratory 18FDG-PET and MRI study

by Marta Torres-Ferrus, Deborah Pareto, Victor J Gallardo, Gemma Cuberas-Borrós, Alicia Alpuente, Edoardo Caronna, Adrià Vila-Balló, Carles Lorenzo-Bosquet, Joan Castell-Conesa, Alex Rovira, Patricia Pozo-Rosich
Published 2021-07-01

Quality assurance in specialized headache units in Spain: an observational prospective study

by Patricia Pozo-Rosich, Alba Martínez-García, Julio Pascual, Emilio Ignacio, Ángel L. Guerrero-Peral, José Balseiro-Gómez, Jesús Porta-Etessam, Germán Latorre-González, Almudena Layos-Romero, César Lucas, José J. Mira
Published 2019-06-01

European headache federation consensus on the definition of resistant and refractory migraine

by Simona Sacco, Mark Braschinsky, Anne Ducros, Christian Lampl, Patrick Little, Antoinette Maassen van den Brink, Patricia Pozo-Rosich, Uwe Reuter, Elena Ruiz de la Torre, Margarita Sanchez Del Rio, Alexandra J. Sinclair, Zaza Katsarava, Paolo Martelletti
Published 2020-06-01

Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance

by Simona Sacco, Christian Lampl, Antoinette Maassen van den Brink, Valeria Caponnetto, Mark Braschinsky, Anne Ducros, Patrick Little, Patricia Pozo-Rosich, Uwe Reuter, Elena Ruiz de la Torre, Margarita Sanchez Del Rio, Alexandra J. Sinclair, Paolo Martelletti, Zaza Katsarava, On behalf of the Burden and Attitude to Resistant and Refractory (BARR) Study Group
Published 2021-05-01

High-frequency repetitive transcranial magnetic stimulation at dorsolateral prefrontal cortex for migraine prevention: A protocol for a systematic review of controlled trials.

by Nabil Izzaatie Mohamad Safiai, Nur Afiqah Mohamad, Hamidon Basri, Liyana Najwa Inche Mat, Fan Kee Hoo, Anna Misyail Abdul Rashid, Abdul Hanif Khan Yusof Khan, Wei Chao Loh, Janudin Baharin, Aaron Fernandez, Intan Nureslyna Samsudin, Mohd Hazmi Mohamed, Mooi Ching Siew, Kai Wei Lee, Vasudevan Ramachandran, Patricia Pozo-Rosich, Wan Aliaa Wan Sulaiman
Published 2021-01-01

MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention

by Robert Belvís, Pablo Irimia, Patricia Pozo-Rosich, Carmen González-Oria, Antonio Cano, Javier Viguera, Belén Sánchez, Francisco Molina, Isabel Beltrán, Agustín Oterino, Elisa Cuadrado, Angel Gómez-Camello, Miguel Alberte-Woodward, Carmen Jurado, Teresa Oms, David Ezpeleta, Javier Díaz de Terán, Noemí Morollón, Germán Latorre, Marta Torres-Ferrús, Alicia Alpuente, Raquel Lamas, Carlos Toledano, Rogelio Leira, Sonia Santos, Margarita Sánchez del Río
Published 2021-07-01